AAAlice Beathe Andersgaard

Alice Beathe Andersgaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alice Beathe Andersgaard has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study

    by Alice B. Andersgaard, Ganesh Acharya, Ellisiv B. Mathiesen, Stein H. Johnsen, Bjørn Straume, Pål Øian


  • Follow-Up Interviews after Eclampsia

    by Alice Beathe Andersgaard, Andreas Herbst, Marianne Johansen, Anna Borgström, Anna Gry Bille, Pål Øian

    Background/Aims: The aim of the study was to assess the prevalence of persisting symptoms 6 months or more after eclampsia. Methods: During a 2-year period (mid-1998 to mid-2000), 210 patients with eclampsia were included in a prospective cohort study of eclampsia in Denmark, Norway and Sweden. One hundred and twenty-three women (59%) were followed up with a structured telephone interview, 6–24 months (median 11) after their eclamptic fit. Results: At the time of follow-up, 63 women (51%) had at least one persistent symptom; 2 patients had severe neurological sequels (hemiparesis and dysarthria), 11% had visual disturbances, 22% had problems concentrating or recalling phone numbers and messages, 18% reported frequent headaches and 10% had vertigo or balance problems. Conclusion: Although few women suffered from severe sequels, many women had persisting symptoms following eclampsia indicating a need for follow-up of these patients. A case-control study comparing the health and symptoms between women having suffered from eclampsia and women without this complication may therefore be justified.


  • Open Access

    Direct maternal deaths in Norway 1976–1995

    by Alice Beathe Andersgaard, Jens Langhoff‐Roos, Pål Øian

    Aims. To report direct maternal mortality ratio (MMR) in Norway between 1976 and 1995 including a description of the underlying complications in pregnancy, the causes of death and assessment of standard of care. Methods. The maternal deaths were identified through the Cause of Death Registry, Statistics Norway, and Medical Birth Registry of Norway. We requested copies of the hospital case records and the maternal death autopsies. The direct maternal deaths were classified on the basis underlying causes and assessed for substandard care according to the guidelines at the time of death and preventability provided optimal conditions and up to date guidelines. Results. In the period 1976–1995 we identified 61 direct maternal deaths in Norway. The direct MMR was 5.5/100,000 births. Sufficient information was available for analysis in 51 of these cases. Six deaths occurred in early pregnancy. Among the 45 women who gave birth, 32 had a cesarean section, and the death was judged to be related to a complication of the operation in more than half of these cases. The standard of care and the possibility of preventing death were evaluated in 49 cases. Substandard care was observed in 21 of them and 27 were considered avoidable or potentially avoidable. Conclusion. The direct MMR in Norway was 5.5/100,000 births. The main causes were complications of hypertensive disease of pregnancy and thromboembolism. The majority of maternal deaths were associated with cesarean delivery and considered potentially avoidable.


  • Eclampsia in Scandinavia: incidence, substandard care, and potentially preventable cases

    by Alice Beathe Andersgaard, Andreas Herbst, Marianne Johansen, Anna Ivarsson, Ingemar Ingemarsson, Jens Langhoff‐Roos, Tore Henriksen, Bjørn Straume, Pål Øian

    Background. Description of incidence, clinical signs, symptoms, and consequences of eclampsia in Scandinavia, and assessment of substandard care and potential preventability. Methods. A descriptive cohort study including all women giving birth in a 2‐year period (mid‐1998–mid‐2000) in Scandinavia. Notifications of eclampsia cases were obtained from all obstetric units at 3‐monthly intervals. All patient files were reviewed, and systematic audit was performed to identify potentially preventable cases by using predefined criteria. Main outcome measures. Signs and symptoms preceding the eclamptic seizure, the standard of medical care, maternal and perinatal morbidity, and mortality were all recorded. Potentially preventable cases through improved care and cases eligible for primary prophylactic magnesium sulfate (MgSO4) were estimated. Results. The incidence of eclampsia was 5.0/10 000 maternities (CI = 4.3–5.7/10 000). Eighty‐six percent had a diagnosis of pre‐eclampsia before the seizure. Nine of 10 had at least one physical complaint before the first seizure, severe headache being the most common symptom, occurring in two‐thirds. Most seizures (90%) occurred after admission to hospital. By audit, 89 cases (42%) were classified as having received substandard care. Prophylactic use of magnesium sulfate might have reduced the number of eclampsia cases by 35 (17%). Conclusions. Eclampsia occurred mainly in hospital and the majority of women had symptoms heralding the seizure. In retrospect, nearly half of the cases were found potentially preventable by timely intervention, improved medical care, and systematic use of prophylactic treatment with MgSO4.